Regulatory Compliance and Gap Analysis
Procedure: Regulatory Compliance and Gap Analysis
Country: Global Procedure
Version #: 11/27/2023
Author: Daria Kostiuchenko
Editor: Daria Kostiuchenko
ID: GP-PhR-GAP-SR
Category: Pharmaceuticals
Validity: Until MA Application
Certified by: Vlad Reznikov
Copyright: Pattern of USA Inc.
SUMMARY
Gap analysis involves assessing and identifying any shortcomings or gaps in a registration dossier compliance with local regulatory standards. These gaps could include missing documentation, incomplete testing, or lack of adherence to specific guidelines. Unlike risk assessments that concentrate on identifying potential risks and vulnerabilities, gap analysis primarily aims to identify discrepancies between the current state of compliance and the desired level mandated by regulatory requirements to address shortcomings.

Must-Have Requirements, Recognized Standards, and Certifications:
- Registration file with technical documentation in available format
Nice-to-have:
- Regulatory Intelligence and Strategic Consulting see GP-PhR-RI-SR card
- Intellectual Property Rights Protection see GP-PhR-IP-SR card
Typical Gaps and Deficiencies: Incomplete documentation, non-compliance with regulatory guidelines, missing standards
Implementation Period: Immediately
Deliverables: Compliance Enhancement, Action Plan & Gap Analysis Report
PHASE |
TASK |
TASK |
START |
DURATION |
Fee |
KPI |
||
NUMBER |
TITLE |
OWNER |
W/M/Q/Y |
in weeks |
3rd Party |
Service |
State |
|
0 |
In-house Pre-Submission Activity |
|||||||
0.1 |
NDA signing or validation |
Executor |
week 1 |
1 |
||||
0.2 |
Contract Closing |
MAH |
week 1 |
1 |
||||
0.3 |
Invoice is sent to MAH and paid |
Executor |
week 2 |
1 |
||||
0.4 |
SOW is approved by MAH |
Executor |
week 2 |
1 |
SOW |
|||
I |
Gap Identification |
|||||||
I.1 |
Input information obtaining |
MAH |
week 3 |
1 |
||||
I.2 |
Identification of the relevant regulatory requirements |
Executor |
week 4 |
2 |
||||
I.3 |
Identification of risks, deficiencies, gaps in registration file |
Executor |
week 4 |
2 |
||||
I.4 |
Identification of gaps in production, labeling, QA & reporting |
Executor |
week 4 |
2 |
Report |
|||
II |
Address the concerns |
|||||||
II.1 |
Assess non-compliance effects for MA |
Executor |
week 6 |
1 |
||||
II.2 |
Address Gaps for regulatory compliance to MAH |
Executor |
week 6 |
1 |
Report |
|||
III |
Resolve the problem |
|||||||
III.1 |
High-risk areas to mitigate risks prioritization |
Executor |
week 7 |
1 |
||||
III.2 |
Discrepancy mitigation strategy development with CAPA |
Executor |
week 7 |
2 |
||||
III.3 |
CAPA for procedural changes by MAH |
MAH |
week 9 |
1 |
||||
III.4 |
CAPA for conducting personnel training by MAH |
MAH |
week 9 |
1 |
||||
III.5 |
CAPA for conducting personnel training by MAH |
MAH |
week 9 |
1 |
||||
III.6 |
Ensure alignment with local regulatory guidelines |
Executor |
week 10 |
1 |
||||
III.7 |
Registration dossier adjustment with relevant local updates |
Executor |
week 11 |
2 |
Master-file |
|||
F |
Final Phase In-house Post-Authorization Activity |
|||||||
F.1 |
Service Acceptance Certificate signing |
MAH |
week 13 |
1 |
||||
F.2 |
Final Invoice |
Executor |
week 13 |
1 |
||||
F.3 |
Final Payment |
MAH |
week 14 |
1 |
||||
F.4 |
Contract Termination |
Executor |
week 14 |
1 |
||||
F.5 |
Archiving and limiting access |
Executor |
week 15 |
1 |
Archiving |
Feel free to submit a Request for Proposal (RFP) for a specific country or territory to info@patternofusa.com